Health Cabinet Secretary Cabinet Secretary Aden Duale has announced the securing of KSh 2.4 billion for all 47 counties under the Building Resilient and Responsive Health Systems (BREHS) program across the country.
The funding allocation targets devolution units that have successfully executed their Implementation Performance Agreements (IPAs). The funding unlocks financial support meant to strengthen grassroots health systems and enhance public service delivery.
Writing on his official X account on Friday, September 4, 2026, Duale says the funds will improve healthcare delivery, strengthen primary healthcare systems and enhance Kenya’s ability to prepare for health emergencies.
“Under BREHS, KSh 2.4 billion has been secured for the 47 counties that have signed their Implementation Performance Agreements, with KEMSA finalising procurement of essential medicines ahead of distribution to primary healthcare facilities from October 2026.” Duale stated
The Cabinet Secretary disclosed the milestone following high-level discussions held at the Ministry headquarters with a visiting World Bank delegation led by Ronald Mutasa. The discussion focused on accelerating Kenya’s ongoing health sector transformation agenda.
The bilateral engagement centered on evaluating and strengthening the strategic partnership between the Government of Kenya and the World Bank around two flagship healthcare investments valued at a total of Ksh. 43 billion.
According to the Ministry, the BREHS project and the Kenya Health Emergency Preparedness, Response and Resilience (KHEPRR) initiative serve as foundational pillars for advancing Universal Health Coverage (UHC) nationwide.
These combined flagship investments are engineered to build healthcare architecture capable of preventing, detecting, and responding to emerging public health emergencies and localized disease threats.
Under the emergency preparedness framework through KHEPRR, the government is actively advancing local vaccine manufacturing capacity by establishing a state-of-the-art fill-and-finish facility in collaboration with BioVax, the Pharmacy and Poisons Board (PPB), and the National Quality Control Laboratory (NQCL). The initial batch of locally processed vaccines will be rolled out by June 2027.
Beyond biological manufacturing, the multi-billion project focuses on strengthening national laboratory capacity, refining disease surveillance networks, regulatory oversight, and cementing emergency response mechanisms across all levels of care.
Both delegations agreed to fast-track fund disbursements, streamline specialized procurement pathways, and extend the KHEPRR execution window through to September 2030 to accommodate Good Manufacturing Practice (GMP) certifications and address emerging fiscal pressures.
Top ministry officials, including Principal Secretary Ouma Oluga and Director Stephen Muleshe, attended the meeting. They agreed to hold a review in December 2026 to check progress and fix any challenges.
